邯郸怀孕初期要检查哪些邯郸阴部长个小疙瘩,邯郸怀孕五个半月照四维彩超,邯郸范燕燕医生,邯郸怀孕早期做哪些检查,邯郸白带多是什么,邯郸怀孕期间要做哪些检查,邯郸市玛丽亚地址

The current pandemic has led many people to spend more time outside this summer, with many setting up backyard pools or heading to lakes and beaches. But all of that water recreation has led to a spike in drownings."We were seeing it across a national level and when we looked at our local data, we saw that we were following as part of that trend," said Dawne Gardner, an Injury Prevention Specialist with Cincinnati Children's Hospital. Normally, they see anywhere from one to three child drowning deaths a year. This summer, they've seen nine."We know that with parents, they're looking for alternative vacations and things are limited right now with COVID-19 and still being able to social distance. We know that with those limited options, parents are utilizing backyard pools more," said Gardner. Gardner says it may seem safe to have your child swimming in your backyard but she says safety goes way beyond location. Supervision is key."You can't be distracted. So, when kids are in and around water, parents have to be on top of the supervision. Every second counts. And if you take your eyes off of them in the water even for a second, that could be that quiet second that a child slips under water," said Gardner.Other areas of the country also saw a dramatic change in the number of child drownings, but not all were bad. Johns Hopkins All Children's Hospital in St. Petersburg, Florida reported that from March through June, doctors saw a 150 percent increase in child drownings and near-drownings compared to the same time period last year. While at Valley Children's Hospital in Fresno County, California, officials reported a sharp decline in child drownings. The shelter-in-place restrictions from the COVID-19 pandemic don't just prompt families to take part in more water-related activities, they did so at a time when most swimming lesson facilities had to shut down.It was a concern for Aqua-Tots that kids were missing out on a crucial time for swim lessons. "It was incredibly hard to close the doors to our businesses at such a crucial time of year where families and children are outside in the heat and they're flocking to bodies of water. They're swimming a lot more often so it was very tough," said franchise owner Lindsay Thayer of Aqua-Tots. Aqua-Tots has 100 locations in 14 different countries, including here in the U.S. They teach swimming lessons to children, teens and adults. Thayer says to help prevent accidental drownings, children need to learn water safety."Children need to know that they need to ask permission, when to approach a body of water, when to get into a pool or lake with mom or dad, a guardian or adult before doing so. Also, swim lessons are especially important. Participating in a formal swimming lesson program can reduce the risk of drowning by 88% in children between the ages of one and four," said Thayer.Jen Deis, the General Manager of Goldfish Swim School near Cincinnati agrees. Goldfish Swim School provided some online tutorial videos for parents to help them teach their children some basic swimming skills. But she says swim lessons, even during the winter, are vital."Swimming is like any other sport or skill. Kids need constant reinforcement of those swim skills to remember those water safety skills year round. While, right now it is a top priority, with kids around bodies of water a lot of times, keeping them consistent in their swim lessons is really important," said Deis.Cincinnati Children's Hospital reports the nine drowning victims ranged in ages from young children to teenagers. Ensuring fences or other barriers are around pools is also important.They're urging parents to be vigilent when it comes to keeping your children safe around water, hoping to prevent any more accidental drowning deaths this summer. 3807

The Food and Drug Administration says it is re-examining the safety of a medication that was approved despite concerns that not enough was known about the drug's risks.In response to questioning at a budget hearing last week, FDA Commissioner Scott Gottlieb told members of Congress that he would "take another look" at Nuplazid, which is the only drug approved to treat hallucinations and delusions associated with Parkinson's disease psychosis.The medication has been cited as a so-called "suspect" medication in hundreds of deaths voluntarily reported by caregivers, doctors and other medical professionals since it hit the market, as highlighted in a recent CNN report.The FDA told CNN this week that the agency had already begun conducting a new evaluation of the medication when Gottlieb was questioned about it at the hearing. The agency said the review had started several weeks ago."What does it take for a drug like this to be taken off the market?" asked US Rep. Rosa DeLauro, a member and former chair of the congressional subcommittee responsible for funding and overseeing the FDA.DeLauro pressed Gottlieb for answers on his agency's response to the safety concerns surrounding Nuplazid."How many more adverse events do we have to have reported? How many people, quite frankly, have to die? Why does the industry always take precedence over public health and safety?"Tracked by the FDA, the adverse event reports cited by DeLauro do not mean that a suspected medication has been ruled the cause of harm and are typically not the result of official investigations. But the FDA uses the information to monitor potential issues with a drug and can take action as needed: updating a medication's label, for instance, or restricting its use. In rare cases, the agency can even pull a drug off the market.When asked by CNN about what prompted the FDA's new evaluation of Nuplazid, the agency said the decision was based on a number of factors but wouldn't say what those factors were. Instead, it would only comment generally, saying that it identifies "potential signals of serious risk/new safety information" in part by using adverse event data and that the agency is not suggesting physicians stop prescribing the drug or take patients off of it while a safety evaluation is taking place.The FDA has noted that the death reports citing Nuplazid have typically involved elderly patients with advanced-stage Parkinson's disease who suffered from numerous medical conditions and often take other medications that can increase the risk of death.But physicians, researchers and other medical experts told CNN that the high number of reports deserved a closer look to determine whether they were related to the drug. They also recommended further testing of Nuplazid, worrying that the drug had been approved too quickly, based on too little evidence that it was safe or effective.Nuplazid's review was expedited by the FDA because it had been designated a "breakthrough therapy," meaning it demonstrated "substantial improvement" in patients with serious or life-threatening diseases compared to treatments already on the market.Dr. Paul Andreason, the physician who led the FDA's medical review of Nuplazid, warned that patients taking the drug during the company's clinical trials experienced serious outcomes, including death, at more than double the rate of those taking the placebo. But the FDA ruled that the potential benefits outweighed the risks, agreeing with an advisory committee that cited a lack of safe alternatives and the pleas from family members who claimed the drug was already helping or could help their loved ones.At that advisory committee meeting two years ago, one woman said that her grandmother had been part of the clinical trials for the drug and that Nuplazid had been life-changing."We didn't know what to expect or even if she was on the drug" or a placebo, said Zoey Wade. "We soon realized that she must be taking the drug, because she really returned to herself. Her hallucinations reduced, and she better understood what was real and what was imaginary."Shortly after Nuplazid's release, however, patients' family members, doctors and other health care professionals started reporting "adverse events" possibly linked to the medication -- including deaths, life-threatening incidents, falls, insomnia, nausea and fatigue.During the first 10 months Nuplazid was on the market, 244 deaths were reported to the FDA in which Nuplazid was a "suspect" medication, according to an analysis conducted by the Institute for Safe Medication Practices. FDA data now show that the number of reported deaths has risen to more than 700. In more than 1,000 reports, patients continued to experience hallucinations while on Nuplazid.After CNN published its investigation on Nuplazid, reporters were contacted by family members who said the drug helped tame hallucinations with few apparent side effects and others who said they believe Nuplazid contributed to their family member's decline or death. Some said they had not yet reported these experiences to the drugmaker or the FDA.While the FDA has long been criticized for being too slow to approve drugs, DeLauro seized on its push to streamline the process, lambasting the agency for putting industry interests and efficiency above public health and safety.DeLauro described the number of adverse events and deaths as "staggering" and "unprecedented." She also expressed concern that the drugmaker, Acadia Pharmaceuticals, is attempting to get the drug approved for a larger population: patients who suffer from dementia-related psychosis."I don't know why it should stay on the market, especially when the FDA has not determined it to be safe and while the number of adverse events continues to soar," she told Gottlieb.In response to the congresswoman's remarks, Acadia told CNN that adverse event data alone are "not a comprehensive and accurate indicator of the safety profile of any drug." In response to CNN's earlier report on the drug, Acadia said there are a number of reasons for the higher volume of death reports, including the fact that the company distributes Nuplazid through a network of specialty pharmacies that puts the company in more frequent contact with both patients and caregivers -- meaning Acadia is more likely to receive reports of death, which it is required to pass along to the FDA.Commissioner Gottlieb told the committee that the FDA is careful about the decisions it makes and that there may be a higher tolerance for risk in situations where there is an unmet medical need, "so long as the patient is properly informed of what those risks are." This echoed what he told CNN's Dr. Sanjay Gupta in an interview earlier this month.The FDA previously told CNN that it was aware of Nuplazid's "complex safety profile" at the time of approval and required the drugmaker to place warnings on its labeling. The agency also said that, though it was continuing to monitor available information about Nuplazid, it had "not identified a specific safety issue" not already reflected on the medication's label.DeLauro's office told CNN that it plans to follow up with the FDA about its inquiry into Nuplazid. 7224

The COVID-19 pandemic changed all industries, including those for celebrities. Forbes says the world’s highest-paid celebrities brought in a combined 0 million less in 2020 compared to 2019.But don’t feel too bad for them, the top 10 list earned a combined .1 billion this year before taxes and fees.The top earner in 2020, according to Forbes, was Kylie Jenner, who brought in 0 million, mostly from selling a majority stake in her cosmetics firm.Number two stays in the family; Kanye West, Jenner’s brother-in-law, brought in 0 million this year, helped by his Yeezy sneakers deal with adidas.Pandemic-impacted sports cancellations couldn’t dent Roger Federer, Cristiano Ronaldo or Lionel Messi, apparently, Forbes has the three athletes at number 3, 4 and 5 on their list, respectively. Each brought in just over 0 million in 2020, likely helped by endorsement deals and multi-year contracts.Other athletes in the top 10 include Neymar at number 7, who brought in .5 million, and LeBron James at number 9, with .2 million.In September, Forbes announced Tyler Perry was officially a billionaire, owning the rights to his 20-plus movies and continuing to produce content during the pandemic. He also makes the list of top 10 highest-paid celebrities of 2020 at number 6, reportedly bringing in million this year.Howard Stern is the highest-paid radio host, thanks to his eight-figure contract with SiriusXM, and is number 9 on the list of 2020 earners with million for the year.Rounding out the top 10 is Dwayne Johnson, who brought in .5 million this year, mostly from payments for forthcoming movies.Forbes observes the coronavirus pandemic has impacted celebrities in different ways. As live events, like concert tours and sports games, were cancelled and took away potential revenue, online and streaming opportunities like Netflix content deals provided new income.For reference, Forbes reported Taylor Swift, Kylie Jenner and Kanye West as the top three highest-paid celebrities of 2019. Swift topped the list last year with 5 million in 2019. She fell to number 25 on the highest-paid list in 2020. 2148

The city manager for Alameda, California, said a formal investigation is underway following the arrest of a man dancing in a street as part of his exercise routine.The man, Mali Watkins, was charged with resisting arrest. Why he was arrested in the first place is unclear.On May 23, two officers from Alameda Police approached the man after police received a report that a man was dancing in the street. When police arrived, they discovered Mali dancing in the street.When asked why he was dancing, Mali stated it was part of his exercise routine.After Mali began to walk away, videos show officers grabbing Mali by the wrist and detaining him. Mali was told if he resisted, he would be charged with resisting arrest, which is what happened.The city of Alameda said that the man is a resident of the city and is African American.“At this time, I do not know the reasons why the initial officers approached the call the way they did. I am hopeful that an investigation will provide better understanding to that question,” City Manager Eric Levitt said.In the last few days, the city has released body warn camera footage from the incident, in addition to a call into the police’s non-emergency line. Those clips can be viewed here.Levitt said that the reason video from the incident took two weeks to be released was due to privacy concerns. 1348

The entire cast of the "Guardians of the Galaxy" films signed an open letter in support of James Gunn, the director of the series' first two films.Gunn was recently fired as the director of the upcoming third movie after it was revealed he made a number of offensive jokes on Twitter between 2008 and 2012.We are not here to defend his jokes of many years ago but rather to share our experience having spent many years together on that set making Guardians of the Galaxy 1 and 2. The character he has shown in the wake of his firing is consistent with the man he was every day on set, and his apology, now and from years ago when first addressing these remarks, we believe is from the heart, a heart we all know trust and love," the letter reads in part.The letter was signed by actors Dave Bautista, Bradley Cooper, Vin Diesel, Sean Gunn, Karen Gillan, Pom Klementieff, Karen Killan, Christ Pratt, Zoe Saldana and Michael Rooker.Read the letter in its entirety in the tweet below.  1005